Extensible Immunofluorescence (ExIF) accessibly generates high-plexity datasets by integrating standard 4-plex imaging data.

Journal: Nature communications
Published Date:

Abstract

Standard immunofluorescence imaging captures just ~4 molecular markers (4-plex) per cell, limiting dissection of complex biology. Inspired by multimodal omics-based data integration approaches, we propose an Extensible Immunofluorescence (ExIF) framework that transforms carefully designed but easily produced panels of 4-plex immunofluorescence into a unified dataset with theoretically unlimited marker plexity, using generative deep learning-based virtual labelling. ExIF enables integrated analyses of complex cell biology, exemplified here through interrogation of the epithelial-mesenchymal transition (EMT), driving significant improvements in downstream quantitative analyses usually reserved for omics data, including: classification of cell phenotypes; manifold learning of cell phenotype heterogeneity; and pseudotemporal inference of molecular marker dynamics. Introducing data integration concepts from omics to microscopy, ExIF empowers life scientists to use routine 4-plex fluorescence microscopy to quantitatively interrogate complex, multimolecular single-cell processes in a manner that approaches the performance of multiplexed labelling methods whose uptake remains limited.

Authors

  • Ihuan Gunawan
    School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Felix V Kohane
    School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Moumitha Dey
    School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Kathy Nguyen
    Faculté de Médecine, Institut Universitaire d'Anthropologie Médico-Légale, Université Côte d'Azur, 28 Avenue de Valombrose, Nice Cedex 2, 06107, France.
  • Ye Zheng
    College of Artificial Intelligence, Nanjing Agricultural University, Nanjing, China.
  • Daniel P Neumann
    School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
  • Fatemeh Vafaee
    School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • Erik Meijering
    Biomedical Imaging Group Rotterdam, Departments of Medical Informatics and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • John G Lock
    School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia. john.lock@unsw.edu.au.